1 Optimized plant compound with potent anti-biofilm activity across gram-negative species.

2 antimicrobial effect of essential oils: a systematic review

3 Biodegradation of carbazole by a promising gram-negative bacterium

4 In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

5 The evaluation of the synergistic antimicrobial and antibiofilm activity of AamAP1-Lysine with conventional antibiotics against representative resistant strains of both Gram-positive and Gram-negative bacteria

6 Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study

7 Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease

8 In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

9 The threat of carbapenem-resistant gram-negative bacteria in a Middle East region

10 Detection of common mobile genetic elements and genotyping of multidrug-resistant Gram-negative bacilli in blood specimens from septicemia patients in southern China

11 Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand

12 The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action

13 Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations

14 Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria

15 Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

16 Prediction of imipenem-resistant microorganisms among the nosocomial critically ill patients with Gram-negative bacilli septicemia: a simple risk score

17 Different phenotypic and molecular mechanisms associated with multidrug resistance in Gram-negative clinical isolates from Egypt

18 Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis

19 Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital

20 Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria

21 In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

22 In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

23 The evaluation of the synergistic antimicrobial and antibiofilm activity of AamAP1-Lysine with conventional antibiotics against representative resistant strains of both Gram-positive and Gram-negative bacteria

24 Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study

25 Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease

26 In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

27 The threat of carbapenem-resistant gram-negative bacteria in a Middle East region

28 Detection of common mobile genetic elements and genotyping of multidrug-resistant Gram-negative bacilli in blood specimens from septicemia patients in southern China

29 Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand

30 The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action

31 Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations

32 Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria

33 Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

34 Prediction of imipenem-resistant microorganisms among the nosocomial critically ill patients with Gram-negative bacilli septicemia: a simple risk score

35 Different phenotypic and molecular mechanisms associated with multidrug resistance in Gram-negative clinical isolates from Egypt

36 Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis

37 Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital

38 Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria

39 Multicenter Outbreak of Gram-Negative Bloodstream Infections in Hemodialysis Patients.

40 The applicability of gene sequencing and MALDI-TOF to identify less common gram-negative rods (Advenella, Castellaniella, Kaistia, Pusillimonas and Sphingobacterium) from environmental isolates.

41 The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria

42 Inhaled nebulized glatiramer acetate against Gram-negative bacteria is not associated with adverse pulmonary reactions in healthy, young adult female pigs.

43 Increased Serum Immunoglobulin Responses to Gut Commensal Gram-Negative Bacteria in Unipolar Major Depression and Bipolar Disorder Type 1, Especially When Melancholia Is Present.

44 Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana

45 Discovery and characterization of the antimetabolite action of thioacetamide-linked 1,2,3-triazoles as disruptors of cysteine biosynthesis in Gram-negative bacteria.

46 Phenotypic and genotypic determinants of antibiotic resistance of gram-negative bacteria-etiological factors of infectious complications of war wounds

47 Letter to the Editor Regarding "Increasing Frailty Predicts Worse Outcomes and Increased Complications Following Angiogram-Negative Subarachnoid Hemorrhages".

48 Oral colonisation by antimicrobial-resistant Gram-negative bacteria among long-term care facility residents: Prevalence, risk factors, and molecular epidemiology

49 Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature.

50 Screening and Potential of the Incidence of Resistance Transfer Among the Multidrug and Heavy Metal Resistant Gram-Negative Isolates from Hospital Effluents of Northern India.

51 In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli

52 Antimicrobial Resistance among and Therapeutic Options against Gram-Negative Pathogens

53 Multicountry Distribution and Characterization of Extended-spectrum β-Lactamase–associated Gram-negative Bacteria From Bloodstream Infections in Sub-Saharan Africa

54 Dissemination of the Metallo-β-Lactamase Gene blaIMP-4 among Gram-Negative Pathogens in a Clinical Setting in Australia

55 Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

56 Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network

57 Assessment of the Levels of Airborne Bacteria, Gram-Negative Bacteria, and Fungi in Hospital Lobbies

58 Ablation of the Sympathetic Nervous System Decreases Gram-Negative and Increases Gram-Positive Bacterial Dissemination: Key Roles for Tumor Necrosis Factor/Phagocytes and Interleukin-4/Lymphocytes

59 Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance

60 The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida

61 Synergistically-acting Enterocin LD3 and Plantaricin LD4 Against Gram-Positive and Gram-Negative Pathogenic Bacteria.

62 new mouse model for chronic infections by gram-negative bacteria enabling the study of anti-infective efficacy and host-microbe interactions

63 dose-dependent antimicrobial activity of silver nanoparticles on polycaprolactone fibers against gram-positive and gram-negative bacteria

64 gram-negative diplococci in vaginal smear mistaken for child sexual abuse

65 broad bean (vicia faba l.) induces intestinal inflammation in grass carp (ctenopharyngodon idellus c. et v) by increasing relative abundances of intestinal gram-negative and flagellated bacteria

66 spread of tem, vim, shv, and ctx-m β-lactamases in imipenem-resistant gram-negative bacilli isolated from egyptian hospitals

67 antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across india during 2014–2016: study for monitoring antimicrobial resistance trend report

68 novel polymyxin combination with antineoplastic mitotane improved the bacterial killing against polymyxin-resistant multidrug-resistant gram-negative pathogens

69 gram-negative bacterial lipopolysaccharide stimulates activin a secretion from human amniotic epithelial cells

70 antimicrobial resistance patterns among gram-negative bacilli isolated from patients with nosocomial infections: disk diffusion versus e-test

71 susceptibility trends and molecular characterization of gram-negative bacilli associated with urinary tract and intra-abdominal infections in jordan and lebanon: smart 2011–2013

72 antibacterial activity of stenotrophomonas maltophilia endolysin p28 against both gram-positive and gram-negative bacteria

73 changing susceptibility patterns of nonfermenting gram-negative bacilli

74 antibacterial activities of the methanol extracts of albizia adianthifolia, alchornea laxiflora, laportea ovalifolia and three other cameroonian plants against multi-drug resistant gram-negative bacteria

75 outer membrane vesicles (omvs) of gram-negative bacteria: a perspective update

76 tigecycline therapy for nosocomial pneumonia due to carbapenem-resistant gram-negative bacteria in critically ill patients who received inappropriate initial antibiotic treatment: a retrospective case study

77 In vitro activity of arbekacin against multidrug-resistant gram-negative bacilli.

78 Modern Clinician-initiated Clinical Trials to Determine Optimal Therapy for Multidrug-resistant Gram-negative Infections

79 The Association of Aminoglycoside Plasma Levels with Mortality in Patients with Gram-Negative Bacteremia

80 Selective Digestive Tract Decontamination—Will It Prevent Infection with Multidrug-Resistant Gram-Negative Pathogens but Still Be Applicable in Institutions where Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Are Endemic?

81 Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN

82 Antibiotic Regimens and Intestinal Colonization with Antibiotic-Resistant Gram-Negative Bacilli

83 Antibiotic Resistance Caused by Gram-Negative Multidrug Efflux Pumps

84 Association between the point-rating system used for oral health and the prevalence of Gram-negative bacilli in hematological inpatients: A retrospective cohort study

85 Invasive Gram-negative bacilli are frequently resistant to standard antibiotics for children admitted to hospital in Kilifi, Kenya

86 What Infection Control Interventions Should Be Undertaken to Control Multidrug-Resistant Gram-Negative Bacteria?

87 Languid Uptake of Ceftazidime-Avibactam for Carbapenem-Resistant Gram-Negative Infections and Continued Reliance on Polymyxins

88 A multi-point surveillance for antimicrobial resistance profiles among clinical isolates of gram-negative bacteria recovered from major ha’il hospitals, saudi arabia

89 Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged

90 Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

91 Antimicrobial Peptides for Gram-Negative Sepsis: A Case for the Polymyxins

Keyword Connections

Journals

Research Groups

Bibliographies